Investing.com – Mizuho raised its price target on Spyre Therapeutics shares (NASDAQ:SYRE) to $84 from $53 while maintaining an Outperform rating. The stock surged to $63.18, up from a previous close of $51.77, reflecting investor enthusiasm following the trial results. The biotech has delivered a remarkable 320% return over the past year. The price target […]
Hot this week
Business
Auto-component maker Sundram Fasteners’ Q3 net profits at Rs 116.19 cr
Auto-component maker Sundram Fasteners Ltd has reported a...
Global News
Quick Facts About Mexico’s Jewish President-elect, Claudia Sheinbaum
Mexico elected a new president this week, with...
Israel News
How Does The Dichotomy Of Secularism And Religion Manifest In Israeli Politics?
Over the years, the interplay between secularism and religion...
Business
Agritech in Israel – Innovations Transforming Global Agriculture
With a wealth of innovative technologies, Israel has emerged...
Israel News
Mamdani calls for a permanent end to NYC investments in Israel Bonds
New York City Mayoral Candidate Zohran Mamdanni on...
Topics
Related Articles
Popular Categories
Previous article![A Planet Parade Starts This Week: How to View Four Planets in the Sky]( "A Planet Parade Starts This Week: How to View Four Planets in the Sky")
Next article![Sponsors back out of London festival that invited Ye to headline despite record of antisemitism]( "Sponsors back out of London festival that invited Ye to headline despite record of antisemitism")
